Novozymes A/S (CPH:NSIS.B)
350.60
+8.60 (2.51%)
At close: Mar 20, 2026
Novozymes Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 275.3 | 280 | 149.7 | 139.95 | 129.52 |
Cash & Short-Term Investments | 275.3 | 280 | 149.7 | 139.95 | 129.52 |
Cash Growth | -1.68% | 87.04% | 6.97% | 8.06% | -18.37% |
Accounts Receivable | 752.4 | 689.2 | 506.1 | 484.66 | 401.87 |
Other Receivables | 163 | 174 | 77.1 | 72.33 | 108.27 |
Receivables | 915.4 | 863.2 | 583.2 | 556.98 | 510.14 |
Inventory | 772.2 | 720.6 | 486.7 | 511.27 | 402.41 |
Prepaid Expenses | - | - | - | 23.39 | - |
Other Current Assets | 20.3 | 15.6 | 49.9 | 10.76 | 10.09 |
Total Current Assets | 1,983 | 1,879 | 1,270 | 1,242 | 1,052 |
Property, Plant & Equipment | 2,998 | 2,968 | 1,654 | 1,623 | 1,370 |
Long-Term Investments | 17.5 | 24 | 27.5 | 29.98 | 3.9 |
Goodwill | 6,193 | 5,605 | 265 | 269.82 | 271.68 |
Other Intangible Assets | 4,896 | 4,419 | 343 | 361.78 | 404.02 |
Long-Term Deferred Tax Assets | 242.2 | 275 | 236.4 | 218.2 | 220.17 |
Other Long-Term Assets | 19.5 | 24.7 | 14.2 | 16.67 | 9.28 |
Total Assets | 16,349 | 15,196 | 3,809 | 3,762 | 3,331 |
Accounts Payable | 420.8 | 423.1 | 216.9 | 251.27 | 200.4 |
Accrued Expenses | - | - | - | 93.17 | 92.13 |
Current Portion of Long-Term Debt | 1,671 | 236.9 | 432 | 392.43 | 287.68 |
Current Portion of Leases | 30.4 | 29.5 | - | 16.54 | 16.41 |
Current Income Taxes Payable | 116.7 | 60.9 | 24.6 | 43.83 | 65.36 |
Current Unearned Revenue | 26 | 22.8 | 8.7 | 18.55 | 21.92 |
Other Current Liabilities | 476.3 | 315.1 | 290.5 | 120.32 | 79.08 |
Total Current Liabilities | 2,741 | 1,088 | 972.7 | 936.1 | 762.99 |
Long-Term Debt | 1,145 | 1,366 | 612 | 486.54 | 494.94 |
Long-Term Leases | 159.2 | 164.4 | - | 38.72 | 48.42 |
Long-Term Unearned Revenue | 79.9 | 105.3 | 20.4 | 17.34 | 13.18 |
Long-Term Deferred Tax Liabilities | 1,316 | 1,256 | 263.6 | 222.23 | 179.82 |
Other Long-Term Liabilities | 52.7 | 39.7 | 15.1 | 148.29 | 190.04 |
Total Liabilities | 5,494 | 4,020 | 1,884 | 1,849 | 1,689 |
Common Stock | 125.5 | 125.6 | 75.4 | 75.56 | 75.85 |
Retained Earnings | 11,159 | 11,032 | 1,846 | 1,756 | 1,520 |
Comprehensive Income & Other | -428.8 | 18 | -45.4 | 28.64 | -5.38 |
Total Common Equity | 10,855 | 11,176 | 1,876 | 1,860 | 1,591 |
Minority Interest | - | - | 50 | 52.57 | 50.97 |
Shareholders' Equity | 10,855 | 11,176 | 1,926 | 1,913 | 1,642 |
Total Liabilities & Equity | 16,349 | 15,196 | 3,809 | 3,762 | 3,331 |
Total Debt | 3,005 | 1,797 | 1,044 | 934.22 | 847.45 |
Net Cash (Debt) | -2,730 | -1,517 | -894.3 | -794.27 | -717.93 |
Net Cash Per Share | -5.85 | -5.46 | -3.22 | -2.85 | -2.56 |
Filing Date Shares Outstanding | 465.91 | 277.9 | 464.62 | 276.6 | 277.11 |
Total Common Shares Outstanding | 465.91 | 277.9 | 277.32 | 276.6 | 277.11 |
Working Capital | -758.1 | 791.1 | 296.8 | 306.25 | 289.16 |
Book Value Per Share | 23.30 | 40.22 | 6.76 | 6.73 | 5.74 |
Tangible Book Value | -233.2 | 1,152 | 1,268 | 1,229 | 914.97 |
Tangible Book Value Per Share | -0.50 | 4.14 | 4.57 | 4.44 | 3.30 |
Land | 1,678 | 1,692 | - | 1,037 | 1,016 |
Machinery | 2,735 | 2,695 | - | 2,049 | 1,971 |
Construction In Progress | 724 | 619.8 | - | 389.34 | 117.82 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.